Bryce Alden Harrison

This inventor holds 14 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Lexicon Pharmaceuticals, Inc., Harvard College, Other. Active years: 2007-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bryce Alden Harrison. Retrieved from https://idiyas.com/inventor/bryce-alden-harrison-q4gfmxzo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 2)

% Patents Active = 92.9

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 38(Granted Patents)

Company Filing History:

12 out of 89

Lexicon Pharmaceuticals, Inc.

1 out of 834,570

Other

patents

Years Active: 2007-2018

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10106569 - Inhibitors of sodium glucose transporter 1 for constipation (2018-10-23),

2. 9688710 - Inhibitors of sodium glucose cotransporter 1 (2017-06-27),

3. 9365602 - Sodium glucose co-transporter inhibitors and methods of their use (2016-06-14),

4. 9200025 - Inhibitors of sodium glucose cotransporter 1 (2015-12-01),

5. 8507672 - Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors (2013-08-13),

6. 8476413 - Sulfanyl-tetrahydropyran-based compounds and methods of their use (2013-07-02),

7. 8450332 - LIMK2 inhibitors, compositions comprising them, and methods of their use (2013-05-28),

8. 8293878 - Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors (2012-10-23),

9. 8193202 - LIMK2 inhibitors, compositions comprising them, and methods of their use (2012-06-05),

10. 8026347 - Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors (2011-09-27),

11. 7846945 - Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use (2010-12-07),

12. 7781577 - Inhibitors of sodium glucose co-transporter 2 and methods of their use (2010-08-24),

13. 7759514 - Mu opioid receptor ligands: methods of use and synthesis (2010-07-20),

14. 7223888 - Mu opioid receptor ligands: methods of use and synthesis (2007-05-29),

Title: The Contributions of Bryce Alden Harrison at Lexicon Pharmaceuticals, Inc.

Introduction: Bryce Alden Harrison is an innovative professional based in the United States. Currently, he contributes his expertise at Lexicon Pharmaceuticals, Inc., where he works alongside notable colleagues such as Hugh Alfred Burgoon and Nicole Cathleen Goodwin. Despite having no patents to his name, Bryce plays a significant role in the research and development landscape.

Latest Patents: As of now, Bryce Alden Harrison does not hold any patents. However, his work at Lexicon Pharmaceuticals, Inc. contributes to various projects that may lead to future innovative breakthroughs and patents.

Career Highlights: Throughout his career, Bryce has demonstrated a strong commitment to the pharmaceutical industry. His role at Lexicon Pharmaceuticals, Inc. involves collaborating on cutting-edge research and the development of new therapies, emphasizing the importance of innovation in addressing complex medical challenges.

Collaborations: Bryce Alden Harrison collaborates closely with esteemed colleagues, such as Hugh Alfred Burgoon and Nicole Cathleen Goodwin. These professional relationships foster a collaborative environment that encourages innovative thinking and the pursuit of solutions within the pharmaceutical realm.

Conclusion: Although Bryce Alden Harrison does not possess any patents, his role at Lexicon Pharmaceuticals, Inc. and his collaborations highlight his contributions to the field of pharmaceutical research and innovation. His work alongside talented colleagues is vital in advancing therapeutic developments that may shape the future of healthcare.

Profile summary based on public USPTO records.